HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
H Drabkin Selected Research
H Drabkin Research Topics
Disease
3
Neoplasms (Cancer)
09/2004 - 03/2000
1
Renal Cell Carcinoma (Grawitz Tumor)
09/2010
1
Neoplasm Metastasis (Metastasis)
09/2004
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2004
1
Carcinoid Tumor (Carcinoid)
09/2004
1
Carcinoma (Carcinomatosis)
09/2004
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2004
1
Lymphatic Metastasis
09/2004
1
Lung Neoplasms (Lung Cancer)
11/2001
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2001
1
Lipoma (Lipomata)
08/2001
1
Leukemia
08/2001
1
Genetic Translocation (Chromosomal Translocation)
08/2001
Drug/Important Bio-Agent (IBA)
2
Proteins (Proteins, Gene)
FDA Link
11/2001 - 08/2001
2
Neuropilin-1
IBA
11/2001 - 03/2000
1
TOR Serine-Threonine Kinases
IBA
09/2010
1
Sirolimus (Rapamycin)
FDA Link
09/2010
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
09/2010
1
Sorafenib (BAY 43-9006)
FDA Link
09/2010
1
Sunitinib (Sutent)
FDA Link
09/2010
1
Cadherins (E-Cadherin)
IBA
09/2004
1
beta Catenin
IBA
09/2004
1
sodium bisulfite
FDA Link
11/2001
1
Amino Acids
FDA Link
11/2001
1
DNA (Deoxyribonucleic Acid)
IBA
11/2001
1
Conditioned Culture Media
IBA
11/2001
1
Neuropilin-2
IBA
11/2001
1
Semaphorins (Semaphorin)
IBA
11/2001
1
Topoisomerase II Inhibitors
IBA
08/2001
1
Zyxin
IBA
08/2001
1
Topoisomerase Inhibitors
IBA
08/2001
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2000
Therapy/Procedure
1
Aftercare (After-Treatment)
08/2001